US FDA approves Mirum's drug for rare bone disorder
25/09/2026 19:57
US FDA approves Mirum's drug for rare bone disorder Sept 25 (Reuters) - The US Food and Drug Administration has approved Mirum Pharmaceuticals' MIRM.O drug to treat a rare bone disorder, the regulator said on Friday.
(Reporting by Kunal Das and Christy Santhosh in Bengaluru; Editing by Jonathan Ananda)
Recent news on Mirum Pharmaceuticals
See all newsMirum Pharmaceuticals Q3 net product sales surge, outlook raised
Brief: Mirum Pharmaceuticals Announces Positive Results From Cohort 2 Of The Pivotal Progress Study Of Atebrioz™ (Zilurgisertib) In Pediatric Patients Aged 6 To <12 Years With Fibrodysplasia Ossificans Progressiva
Mirum climbs on positive late-stage trial results for liver disease drug
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX